KIPClass I
Formulations, Balanced Salt Solutions
21 CFR 864.2875 / Hematology
KIP is the FDA product code for Formulations, Balanced Salt Solutions, a class I device type, regulated under 21 CFR 864.2875. As of , FDA records hold 17 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- KIP
- Device name
- Formulations, Balanced Salt Solutions
- Regulation
- 21 CFR 864.2875
- Device class
- Class I
- Review panel
- Hematology
- Submission type
- 510(k) exempt
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 17
- Ingested recalls
- 0
Clearances, product code KIP
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1978 | 1 |
| 1981 | 3 |
| 1982 | 3 |
| 1984 | 3 |
| 1985 | 2 |
| 1986 | 1 |
| 1987 | 4 |
Applicants with the most clearances
Product code KIP| Applicant | Clearances |
|---|---|
| Dutchland Laboratories, Inc. | 6 |
| Sigma Chemical Co. | 4 |
| E K Ind., Inc. | 3 |
| Hazleton Research Products, Inc. | 2 |
| Flow Laboratories, Inc. | 1 |
| Tissue Culture Innovations | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this code- Chengdu Lanrun Biotechnology Co.,Ltd
- Clinical Diagnostic Solutions, Inc.
- Fbgc Limited
- Gemini Bioproducts LLC
- High Technology, Inc.
- Himedia Laboratories Private Limited
- Incell Corporation, LLC
- Jiangsu Senwo Medical Technology Co., Ltd.
- Lonza Verviers SRL.
- Lonza Walkersville, Inc.
- Mainiusi Intelligent Medical Technology (Suzhou) Co., Ltd.
- Medical Electronic Systems Ltd.
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
